RESTRICTED STOCK (Details Narrative) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Stock Options And Restricted Stock
Non-cash compensation expense	$ 108,000	$ 152,000
Aggregate restricted shares of Common Stock pursuant to 2008 plan			12,550
Shares of non-vested restricted stock			152,743
Total unrecognized compensation expense	$ 550,000		$ 550,000
FDA Approval [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval			51,785
Yearly [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval			100,958